Gritstone Bio Inc (GRTS)
0.808
+0.01
(+0.80%)
USD |
NASDAQ |
May 28, 16:00
0.808
0.00 (0.00%)
After-Hours: 20:00
Gritstone Bio Research and Development Expense (Quarterly): 33.04M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 33.04M |
| December 31, 2023 | 32.94M |
| September 30, 2023 | 32.76M |
| June 30, 2023 | 30.97M |
| March 31, 2023 | 30.51M |
| December 31, 2022 | 29.42M |
| September 30, 2022 | 26.44M |
| June 30, 2022 | 27.35M |
| March 31, 2022 | 28.20M |
| December 31, 2021 | 26.17M |
| September 30, 2021 | 24.40M |
| June 30, 2021 | 22.07M |
| March 31, 2021 | 24.86M |
| December 31, 2020 | 22.84M |
| Date | Value |
|---|---|
| September 30, 2020 | 22.05M |
| June 30, 2020 | 21.29M |
| March 31, 2020 | 22.47M |
| December 31, 2019 | 23.58M |
| September 30, 2019 | 24.89M |
| June 30, 2019 | 18.53M |
| March 31, 2019 | 15.90M |
| December 31, 2018 | 15.25M |
| September 30, 2018 | 15.62M |
| June 30, 2018 | 12.69M |
| March 31, 2018 | 11.40M |
| December 31, 2017 | 15.75M |
| September 30, 2017 | 8.084M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
18.53M
Minimum
Jun 2019
33.04M
Maximum
Mar 2024
26.24M
Average
25.53M
Median
Research and Development Expense (Quarterly) Benchmarks
| Precision BioSciences Inc | 13.34M |
| Humacyte Inc | 21.26M |
| Verastem Inc | 17.71M |
| BioVie Inc | 5.700M |
| Adial Pharmaceuticals Inc | 0.4543M |